News
A wellness influencer named Janelle Rohner has come under fire after withholding the fact that she was using a GLP-1 weight ...
Researchers are beginning to wonder if blockbuster drugs like Wegovy, Ozempic and Zepbound could play a role in preventing ...
Novo's Wegovy has lost market share to Eli Lilly's Zepbound, and a new head-to-head study found that Zepbound patients lost ...
A growing number of South Dakotans are shedding pounds thanks to GLP-1 medications, but now they’re hitting a roadblock.
KFF Health News journalists made the rounds on national and local media recently to discuss topical stories. Here’s a ...
VinFuture Prize holds the distinction of being the first major international science and technology award to recognize and ...
Bariatric surgery for severe obesity including gastric banding is under threat as rocketing indemnity insurance premiums and growing malpractice claims drive surgeons out of the field, experts warn.
Listen to Dr. Ilana Ressler explain PCOS and its significance in fertility and metabolic health on our latest episode.
There is growing evidence that Ozempic and other GLP-1 receptor agonist drugs might help people drink less alcohol, but more ...
16h
NewsNation on MSNStudy: Weight loss drugs could reduce cancer riskThe data showed patients who took GLP-1 drugs had a much lower risk of developing cancer than those who took DDP-4s.
Ozempic, while effective for weight loss, is linked to emerging dental problems termed \"Ozempic teeth.\" Patients report dry ...
As demand for GLP-1 weight-loss medications like Wegovy and Zepbound continues to grow in the United States, so do questions about their affordability.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results